Medical Condition News

RSS

Rutgers-led team secures $6.5 million grant for lung cancer research

A Rutgers-led consortium has been awarded a $6.5 million grant from the National Cancer Institute (NCI) to support next-generation tools to guide tobacco control policies, improve lung cancer screening, strengthen survivorship care, and support state-level cancer prevention planning.

3 Nov 2026

Autism diagnosis patterns change as psychiatric profiles shift across Europe

The medical profiles of adults diagnosed with autism have changed hugely since 2010, finds a study of medical records in the UK and Sweden, published in the online journal BMJ Mental Health.

3 Nov 2026

TAVR procedures increase ninefold among patients younger than 70

New research simultaneously published today in JSCAI and presented at TCT 2026 found that the annual number of transcatheter aortic valve replacement (TAVR) procedures among patients younger than 70 increased nearly ninefold within one health system, rising from 15 in 2014 to 134 in 2024.

3 Nov 2026

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.

3 Nov 2026

Synthetic DNA molecules enable precise targeting of cancer-linked genes

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological research.

3 Nov 2026

Blood may reveal signs of gut-related disease that stool samples miss

In a study of 193 participants, researchers found that blood-based short-chain fatty acid profiles distinguished colorectal cancer, celiac disease, obesity, and healthy controls with 95% accuracy, compared with 59% for stool-based measurements. Combining blood and stool profiles increased accuracy to 97%, suggesting that circulating microbial metabolites may offer valuable diagnostic information, although larger studies are needed to validate the findings.

3 Nov 2026

Natural plant extract reduces cisplatin-induced kidney injury in mice

Acute kidney injury is common in hospitalized patients and rises sharply in intensive care, yet treatment options remain largely supportive.

3 Nov 2026

A low-calorie diet and exercise helped 54% of younger adults achieve diabetes remission

In a randomized clinical trial involving 96 adults with early-onset type 2 diabetes and obesity, a 24-week program combining a low-energy diet with supervised exercise achieved diabetes remission in 54% of participants, compared with 4% receiving usual care. The intervention also reduced body fat, largely preserved muscle mass, and improved strength and body-mass-adjusted fitness, although the additional benefits attributable specifically to exercise remain uncertain.

3 Nov 2026

Memory problems may matter more than slower thinking for dementia risk in frail adults

In a study of 7,023 adults in England, researchers identified three cognitive frailty profiles with different patterns of memory, executive function, and processing speed impairment. Over approximately 10 years, profiles involving memory impairment were associated with higher odds of subsequent dementia, while socioeconomic, educational, and psychosocial factors showed different associations across the three groups.

3 Nov 2026

Heart disease and depression may affect brain aging in an unexpected way

A longitudinal study of 5,423 adults in England found that cardiovascular disease was associated with faster cognitive decline, with the strongest association observed among participants with consistently low depressive symptoms. Those with persistent moderate or high depressive symptoms generally experienced poorer cognitive performance and faster overall deterioration, despite showing a weaker additional association between cardiovascular disease and cognitive decline.

3 Nov 2026

Advanced imaging tool improves detection of residual multiple myeloma disease

A targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, a finding that could help doctors more accurately map disease, guide treatment decisions and confirm whether cancer remains after therapy.

3 Nov 2026

Immune cell neighborhoods control cancer spread and metastasis formation

Published in Nature Cancer: Researchers at the Université libre de Bruxelles (ULB) have discovered that immune cells build distinct "neighborhoods" around cancer cells.

3 Nov 2026

Study highlights overlooked pain from diabetes-related foot ulcers

Diabetes-related foot ulcers are often associated with numbness in the feet. According to patients, the fact that these ulcers can also cause severe and unpredictable pain does not receive sufficient attention within the healthcare system, according to a doctoral thesis from the University of Gothenburg.

3 Nov 2026

Study identifies new target to improve ulcerative colitis treatments

Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease in which persistent mucosal inflammation damages the epithelial barrier.

3 Nov 2026

New initiative provides lung cancer screening for Illinois firefighters

Northwestern Medicine will screen more than 300 firefighters from Chicago and DeKalb, Illinois, for lung cancer through its innovative Lung Health Center at the Canning Thoracic Institute, continuing efforts to detect cancer earlier in populations at increased risk.

3 Nov 2026

New exercise program helps people stay strong through cancer

When you’re going through cancer treatment or recovering afterwards, rest might seem like the best medicine.

3 Nov 2026

1nhaler secures £2.2 million to continue late-stage development

The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

3 Nov 2026

Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins

Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.

3 Nov 2026

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.

3 Nov 2026

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of four newly available IVDR-certified CytoCell® fluorescence in situ hybridization (FISH) probes as part of its ongoing commitment to transition the CytoCell FISH portfolio from CE marking under the IVD Directive (IVDD) to the IVD Regulation (IVDR) ahead of the Class C deadline of 31 December 2028.

3 Nov 2026